IRIS
SCARPIGNATO, Carmelo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 12.676
NA - Nord America 12.503
EU - Europa 6.378
SA - Sud America 1.662
AF - Africa 527
Continente sconosciuto - Info sul continente non disponibili 48
OC - Oceania 15
Totale 33.809
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.150
SG - Singapore 5.155
CN - Cina 3.426
VN - Vietnam 1.706
IE - Irlanda 1.494
BR - Brasile 1.307
SE - Svezia 943
DE - Germania 910
HK - Hong Kong 886
FI - Finlandia 862
TR - Turchia 702
NL - Olanda 443
IT - Italia 435
FR - Francia 389
ZA - Sudafrica 376
UA - Ucraina 324
CA - Canada 219
GB - Regno Unito 186
RU - Federazione Russa 162
IN - India 143
AR - Argentina 134
BD - Bangladesh 110
JP - Giappone 74
IQ - Iraq 70
MX - Messico 70
EC - Ecuador 65
EU - Europa 46
CI - Costa d'Avorio 45
PH - Filippine 45
CO - Colombia 41
PK - Pakistan 40
PL - Polonia 39
ID - Indonesia 35
UZ - Uzbekistan 35
VE - Venezuela 32
ES - Italia 31
BE - Belgio 29
KR - Corea 29
MA - Marocco 27
TH - Thailandia 27
PY - Paraguay 26
SA - Arabia Saudita 26
EG - Egitto 25
AT - Austria 23
CL - Cile 21
IR - Iran 21
LT - Lituania 18
TW - Taiwan 17
AE - Emirati Arabi Uniti 16
KE - Kenya 15
CZ - Repubblica Ceca 14
PE - Perù 14
TN - Tunisia 14
JO - Giordania 13
RO - Romania 13
JM - Giamaica 12
MY - Malesia 12
AU - Australia 11
AZ - Azerbaigian 11
CR - Costa Rica 11
KZ - Kazakistan 11
UY - Uruguay 11
BO - Bolivia 8
HU - Ungheria 8
OM - Oman 8
AL - Albania 7
PA - Panama 7
RS - Serbia 7
BG - Bulgaria 6
DZ - Algeria 6
HN - Honduras 6
IL - Israele 6
NP - Nepal 6
AM - Armenia 5
DO - Repubblica Dominicana 5
LB - Libano 5
NI - Nicaragua 5
SK - Slovacchia (Repubblica Slovacca) 5
TT - Trinidad e Tobago 5
AF - Afghanistan, Repubblica islamica di 4
BH - Bahrain 4
BY - Bielorussia 4
CG - Congo 4
KG - Kirghizistan 4
LV - Lettonia 4
MD - Moldavia 4
NG - Nigeria 4
PS - Palestinian Territory 4
SY - Repubblica araba siriana 4
GE - Georgia 3
GR - Grecia 3
GT - Guatemala 3
LU - Lussemburgo 3
QA - Qatar 3
SN - Senegal 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BS - Bahamas 2
CH - Svizzera 2
DK - Danimarca 2
Totale 33.770
Salva come PNG Salva come JPEG
Città #
Singapore 2.283
Dublin 1.491
Chandler 1.347
Ashburn 1.290
San Jose 1.281
Jacksonville 879
Hong Kong 850
Beijing 730
Santa Clara 701
Izmir 617
Dearborn 604
Nanjing 528
Ho Chi Minh City 519
Boardman 470
San Mateo 423
Hanoi 398
Princeton 391
Johannesburg 359
Lauterbourg 330
Dallas 299
Wilmington 241
Los Angeles 210
Parma 177
Shanghai 176
Shenyang 173
Ann Arbor 154
Helsinki 152
Nanchang 152
Toronto 140
Columbus 134
Hebei 124
São Paulo 112
Moscow 109
Tianjin 108
Kunming 103
Munich 101
Hefei 94
Jinan 91
Seattle 86
Jiaxing 85
New York 85
Changsha 83
Grafing 73
Norwalk 65
Da Nang 64
Buffalo 63
Haiphong 62
Frankfurt am Main 54
Tokyo 54
Guangzhou 53
Turku 44
Abidjan 43
Bremen 43
Brooklyn 42
Kocaeli 42
Houston 39
Rio de Janeiro 37
Des Moines 33
Hangzhou 33
Council Bluffs 32
Düsseldorf 32
London 32
Woodbridge 32
Can Tho 31
Tashkent 31
Belo Horizonte 30
Boston 30
Hải Dương 30
Montreal 30
Warsaw 30
Zhengzhou 29
Chicago 28
Milan 28
Biên Hòa 27
Orem 27
The Dalles 27
Brussels 26
Chennai 26
Atlanta 25
Baghdad 25
Phoenix 25
Guarulhos 24
Porto Alegre 24
Guayaquil 23
Rockville 22
Brasília 21
Stockholm 21
Borås 20
Mumbai 20
San Francisco 20
Dhaka 19
Mexico City 19
Nuremberg 19
Quảng Ngãi 18
Fremont 17
Quito 17
Salvador 17
Ankara 16
Campinas 16
Denver 16
Totale 20.526
Salva come PNG Salva come JPEG
Nome #
Alginate containing formulations: are they all the same? 178
[Effect of cimetidine on acute experimental pancreatitis in the rat]. 169
W1079 Curcumin Vs Domperidon in Functional Dyspepsia: Better the Prokinetic or An Agonist of Vanilloid Receptor? 166
Antacids and alginates in the treatment of gastroesophageal reflux disease: how do they work and how much are they clinically useful? 161
Assembled delivery modules for clarithromycin release in Helicobacter Pylori therapy 156
Dysphagia and clinical outcome after laparoscopic Nissen or Rossetti fundoplication: sequential prospective study 154
Proton pump inhibitors in GORD An overview of their pharmacology, efficacy and safety 153
Myths and misconceptions about chronic constipation 151
Gastric function assessed by Gastropanel in very old patients (over 80 years old) and appropriateness of PPIs administration 150
[Protective effect of ranitidine in acute experimental pancreatitis in the rat]. 148
Is the interval between the first and the second H.P. eradication therapy relevant for the success of the cure? A comparison between one week, one month and one year 147
Caustic injury of the upper gastrointestinal tract: A comprehensive review 145
T1082 Eradication Rate of Helicobacter pylori in Immigrant Patients Compared to Italian Patients: Results of a Clinical Trial 145
ACID SUPPRESSION THERAPY: WHERE DO WE FROM HERE? 144
Corrosive Esophageal Strictures in Children:. Outcomes after Timely or Delayed Dilatation. 143
Gastrin 17 in Singling Out Patients with Different Patterns of Refluxate: A Pilot Study Using Impedance-pH as Reference Standard 143
ASSESSMENT OF SYMPTOMS IN PATIENTS WITH SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE (SUDD) 142
Acid suppression in Barrett's esophagus: why and how? 141
P.02.8: Chronic Atrophic Gastritis is Related with an Increased Risk for Cardiovascular Diseases, Assessed by Homocysteine Serum Levels Determination 140
T1979 Pepsinogen II As Marker of Inflammation in H.P Infection and in NSAIDs Damage 140
M1261 Recurrence of Diverticulitis in Patients With Symptomatic Uncomplicated Diverticular Disease (SUDD) Treated Cyclically With Mesalamine: Result of a Follow-up Study 138
P.1.193: MESALAMINE FOR THE MANAGEMENT OF PATIENTS WITH UNCOMPLICATED DIVERTICULAR DISEASE (SUDD): A 24 MONTHS PROSPECTIVE FOLLOW-UP STUDY 137
P.1.288: PEPSINOGEN I, II, RATIO, AND G-17 IN PATIENTS WITH ESOPHAGITIS AND PATIENTS WITH EXTRA-ESOPHAGEAL MANIFESTATIONS OF GERD 137
P.02.18: Non Invasive Diagnosis of Upper Gi Diseases in a Primary Care Setting: A Study on 1,900 Patients 136
Caustic ingestion in children: is endoscopy always indicated? A perspective from a Sierra Leone experience 135
T1651 The Natural History of Gastric Ulcer: A Twenty-Four Years Clinical-Endoscopical Follow-Up 135
PA.28 SERUM PEPSINOGEN I AS NON INVASIVE MARKER OF GASTRIC ACID SECRETION 135
P.29 USEFULNESS OF NON INVASIVE TEST (GASTROPANEL) FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASE 135
Usefulness of Serum Pepsinogens to Identify Chronic Atrophic Gastritis 133
Corrosive oesophageal strictures in children: outcomes after timely or delayed dilatation 132
OC3.07.1 CURCUMIN VS DOMPERIDON IN FUNCTIONAL DYSPEPSIA: BETTER THE PROKINETIC OR AN AGONIST OF VANILLOID RECEPTOR? 132
Pepsinogen I, II, Ratio, and G-17 in Patients With Esophagitis and Patients With Extra-Esophageal Manifestations of GERD 131
P.01.14: Overweight and Obesity as Risk Factors for Gerd Outcome: A 10 Years Study on a Gerd Population of 365 Patients 131
Evaluation of clinical outcome after laparoscopic antireflux surgery in clinical practice: still a controversial issue. 130
P.01.7: Efficacy of PPIS and H-2 Blockers Therapy on Acid Suppression Assessed by Gastrin-17 and Pepsinogen I Serum Levels Determination in Gerd Patients 130
PA.6 GASTRIN-17 (G-17): A SEROLOGICAL BIO-MARKER FOR DIAGNOSIS OF GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD) 130
Action of MDL 646, a new synthetic prostaglandin, on gastric acid secretion of some experimental animals. 129
"RESCUE" THERAPIES FOR THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION 128
FLOTATION OF DOSAGE FORMS AND DEVICES FOR SITE SPECIFIC THERAPY 128
Antacids and alginate-containing preparations: what is their mechanism of action and their place in the management of GERD? 128
M1260 Effect of Cyclically Long-Term Treatment With Mesalamine in Patients With Symptomatic Uncomplicated Diverticular Disease (SUDD): A 5 Years Follow-up Study 128
A multinational survey of prevalence and patterns of laxative use among adults with self-defined constipation 127
[Cerebral homovanillic acid and audiogenic stress in the rat: effect of Cannabis resin]. 127
M1141 Diagnostic Accuracy of Serum Pepsinogens and Gastrin to Follow-up Helicobacter pylori Infection: A Pilot Study 127
P.05.11 CLINICAL USEFULNESS OF LACTOSE-RESTRICTED DIET IN POSITIVE QUICK LACTASE TEST PATIENTS: PROSPECTIVE 4 MONTHS STUDY 127
ADVANCES IN GI PHARMACOLOGY AND THERAPEUTICS 126
P.02.2: Improvement of Symptoms in Patients Affected by Chronic Athrophic Gastritis: A 2 Years Prospective Study by using L-Cysteine (Acetium™) 126
M1262 Baseline Symptoms in Patients With Symptomatic Uncomplicated Diverticular Disease (SUDD) 126
EFFECTS OF SOME ANTIULCER DRUGS ON ACUTE EXPERIMENTAL PANCREATITIS IN THE RAT. 125
Recovery of Gastric Function in Chronic Atrophic Gastritis By Using L-Cysteine: A 3 Years Study 125
Natural history of gastric ulcer in a 25-years follow-up: role of helicobacter pylori infection and nonsteroidal anti-inflammatory drugs 125
Does the Learning Phase influence the late outcome of patients with gastroesophageal reflux disease after laparoscopic fundoplication? 124
OC.18.1 ARE ALL PATIENTS WITH HISTOLOGICAL DIAGNOSIS OF ATROPHIC GASTRITIS REALLY AT RISK OF DEVELOPING GASTRIC CANCER? ASSESSMENT OF GASTRIC ACID PRODUCTION BY CORRELATION BETWEEN MAXIMAL ACID OUTPUT AND PEPSINOGEN I 124
Esomeprazole immediate release tablets: Gastric mucosa ex vivo permeation, absorption and antisecretory activity in conscious rats 122
P.02.9: Prevalence of Atrophic Gastritis in General Population: A Gastropanel®-Based Study, Compared with Olga Histological Classification 122
Environmental factors (divorce, job changing, night shift change): critical role in IBS outcome. A study on 110 consecutive patients 122
Sa1862 Are All Patients With Histological Diagnosis of Atrophic Gastritis Really At Risk of Developing Gastric Cancer? Assessment of Gastric Acid Production by Correlation Between Maximal Acid Output and Pepsinogen I 121
P.02.1: Individual Assessment of Gastric Acid Production by Means of a Non-Invasive Test: Relationship Between Maximal Acid Output and Serum Pepsinogen I Levels in Patients with Different Upper GI Diseases 121
Can gangrenous cholecystitis be prevented?: a plea against a "wait and see" attitude. 120
Acid-lowering drugs in the treatment of gastroesophageal reflux disease: an overview. 120
Antacid protection of the gastric mucosa: an overview. 120
Antacids in gastroesophageal reflux disease. 120
Non Invasive Diagnosis of Upper GI Diseases in a Primary Care Setting: A Study on 1,900 Patients 120
Antidiarroici ed Antispastici 119
OC.07.3 RECOVERY OF GASTRIC FUNCTION AFTER ACETIUM® ADMINISTRATION: A 2 YEAR PROSPECTIVE STUDY IN PATIENTS WITH CHRONIC, ATROPHIC, BODY GASTRITIS 119
P.02.7: The Branded Proton Pump Inhibitors (PPIS) Increase Levels of Gastrin 17 (G-17) More than the Generic Ones in Dyspeptic Patients from an Italian Primary Care Population 119
Spasmolytic effect of octylonium bromide on gastrointestinal motility in vitro. 117
A simple method for the measurement of human gastric emptying: standardization of operative parameters. 117
In vitro comparison of medicinal products based on alginic acid claimed to protect the esophagus wall and physically prevent acid reflux 117
Distinct receptors mediate gastrin-releasing peptide and neuromedin beta-induced delay of gastric of liquids in rats. 117
Action of caerulein on gastric emptying of the conscious rat. 116
Dysphagia aortica: a neglected symptom of aortoesophageal fistula 116
Sa1988 Recovery of Gastric Function After Helicobacter pylori Eradication and Acetium Administration: A 6 Years Study in Atrophic Gastritis Subjects 116
P.01.11: Gastrin 17 in Singling out Patients with Different Pattern of Gastroesophageal Reflux: A Pilot Study using PH-Impedance as Reference Standard 115
Serum Pepsinogen II as a non-invasive marker for diagnosis of Helicobacter pylori infection: a prospective study in a cohort of dyspeptic patients 115
Monitoring risk factors fot the onset of esophagitis in a long 15-years follow-up 115
The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel 114
P.07.2: Natural History of Symptomatic Uncomplicated Diverticular Disease: A 13-Year Prospective Study 114
Non invasive diagnosis of upper GI disease in a primary care setting: A study on 1900 patients 113
OC.09.2: Appropriateness of PPI Administration in the Elderly: Evaluation of Acid Secretion and Atrophic Gastritis by Means of a Non-Invasive Test 113
P.10 “GASTROPANEL TEST” IN THE CLINICAL OUTCOME OF GERD: PROSPECTIVE SIX MONTHS CLINICAL STUDY 113
How can we measure acid secretion in the single patient? A validated non-invasive surrogate test compared with maximal acid output in 600 people 113
Corrosive esophageal injuries in children. A shortlived experience in Sierra Leone 112
Quantification of serum levels of pepsinogens and gastrin to assess eradication of Helicobacter pylori 111
Commentary: towards an effective and safe treatment of small intestine bacterial overgrowth 111
Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy 111
P.12.12 INTERMITTENT VERSUS EVERY-DAY MESALAZINE THERAPY IN PREVENTING COMPLICATIONS OF DIVERTICULAR DISEASE OF THE COLON: A LONG-TERM FOLLOW-UP STUDY 111
P.04.9 DIAGNOSIS OF CHRONIC ATROPHIC GASTRITIS IN PRIMARY CARE SETTING BY MEANS OF GASTROPANEL®: A POPULATION STUDY ON 10,000 CONSECUTIVE PATIENTS 111
Antisecretory drugs, Helicobacter pylori infection and symptom relief in GORD: still an unexplored triangle 110
Comparing tapentadol to oxycodone/naloxone combination: building castles in the air. 110
Predictive value of the Diverticular Inflammation and Complication Assessment (DICA) endoscopic classification on the outcome of diverticular disease of the colon: An international study 110
P.01.5: Serum Pepsinogen II as a Non-Invasive Marker for Diagnosis of Helicobacter Pylori Infection: A Prospective Study in a Cohort of Dyspeptic Patients 110
[Modalities and diagnostic criteria in esophageal ph monitoring]. 109
P.09.23 OVERLAP OF THREE PATHOLOGICAL CONDITIONS (HELICOBACTER PYLORI INFECTION, YELLOW STOMACH AND LACTOSE INTOLERANCE) IN PATIENTS WITH GASTROINTESTINAL DISORDERS 108
Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats 108
Italian consensus conference for colonic diverticulosis and diverticular disease 108
Nonsteroidal antiinflammatory drug-related injury to the gastrointestinal tract: clinical picture, pathogenesis, and prevention 107
P.04.11 A NEW APPROACH TO DETECTION OF NON-RESPONDER PATIENTS IN GERD BY NON-INVASIVE MARKERS 107
Individual Assessment of Gastric Acid Production by Means of a Non-Invasive Test: Relationship between Maximal Acid Output and Pepsinogen I Levels 107
Gastrointestinal safety of amtolmetin guacyl in comparison with celecoxib in patients with rheumatoid arthritis. Clin Exptl Rheumatol 2005; 23: 809-818 106
Totale 12.676
Salva come PNG Salva come JPEG
Categoria #
all - tutte 124.088
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 124.088
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021242 0 0 0 0 0 0 0 0 0 57 162 23
2021/20221.704 17 4 1 66 61 77 125 308 72 227 201 545
2022/20234.813 671 395 260 341 345 533 20 284 1.779 15 131 39
2023/20241.675 81 177 40 72 177 371 43 117 56 130 178 233
2024/20256.282 87 439 506 250 691 540 109 164 1.056 686 574 1.180
2025/202611.912 1.113 1.252 1.332 1.106 1.910 756 1.617 339 1.726 761 0 0
Totale 33.952